1. Home
  2. MFA vs KURA Comparison

MFA vs KURA Comparison

Compare MFA & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFA Financial Inc.

MFA

MFA Financial Inc.

HOLD

Current Price

$9.42

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

HOLD

Current Price

$9.14

Market Cap

841.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFA
KURA
Founded
1997
2014
Country
United States
United States
Employees
N/A
260
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
841.6M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
MFA
KURA
Price
$9.42
$9.14
Analyst Decision
Buy
Buy
Analyst Count
6
11
Target Price
$11.05
$25.56
AVG Volume (30 Days)
1.4M
1.2M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
14.16%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$67,482,000.00
Revenue This Year
N/A
$28.28
Revenue Next Year
$10.02
$106.37
P/E Ratio
$7.75
N/A
Revenue Growth
N/A
25.24
52 Week Low
$8.78
$5.45
52 Week High
$10.57
$12.49

Technical Indicators

Market Signals
Indicator
MFA
KURA
Relative Strength Index (RSI) 39.44 50.05
Support Level $9.38 $8.95
Resistance Level $10.26 $9.82
Average True Range (ATR) 0.22 0.43
MACD -0.08 -0.02
Stochastic Oscillator 9.55 45.89

Price Performance

Historical Comparison
MFA
KURA

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Share on Social Networks: